Back to search
Palmoplantar Pustulosis (PPP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Palmoplantar Pustulosis (PPP) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Palmoplantar Pustulosis (PPP) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to evaluate the efficacy and safety of bimekizumab compared with placebo in participants with palmoplantar pustulosis (PPP).
Palmoplantar pustulosis (PPP) is a chronic and recurrent skin disease, mainly characterized by erythema, pustules and scales on the palms and soles, often accom…
What's the problem? Palmoplantar pustulosis (PPP) is a long-term skin condition that mainly affects the palms of hands and soles of feet. It causes red, scaly s…
This registry is a prospective observational study in order to describe primarily the natural course of PP subtypes and to gain detailed information about their…
Palmoplantar pustulosis (PPP) is a rare, chronic inflammatory skin disease primarily affecting the palms and soles. Currently, no treatment is specifically appr…
The purpose of this study is to describe the treatment patterns of participants receiving systemic treatment for of palmoplantar pustulosis (PPP) in Japan.